ASIC appeals CBA, Colonial conflicted remuneration decision smsfadviser.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smsfadviser.com Daily Mail and Mail on Sunday newspapers.
Telix Pharmaceuticals (ASX: TLX) has announced it has withdrawn its application to market the company’s lead prostate cancer imaging product, Illuccix, in Europe.
The Federal Court has dismissed proceedings brought by the corporate regulator against a major bank for allegedly breaching conflicted remuneration laws. In a statement, ASIC said the Federal Court ha